$NUS News

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

Nu Skin Enterprises, Inc. 2026 Q2 - Results - Earnings Call Presentation

Nu Skin Enterprises Sees FY2026 GAAP EPS $(4.90)-$(4.73)

Nu Skin Enterprises Sees Q3 GAAP EPS $0.00-$0.09

Nu Skin Enterprises Sees FY2026 Adj EPS $0.70-$0.90 vs $1.00 Est; Lowers FY2026 Sales Guidance from $1.350B-$1.500B to $1.280B-$1.350B vs $1.425B Est

Nu Skin Enterprises Sees Q3 Adj EPS $0.10-$0.20 vs $0.32 Est; Sees Sales $310.000M-$340.000M vs $375.500M Est

Nu Skin Enterprises Q2 Adj. EPS $0.20, Inline, Sales $320.112M Miss $345.200M Estimate

Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results

Nu Skin Enterprises: Working Capital Intensity, A Lot Riding On India

Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?

Nu Skin Enterprises Stockholders Approve Amended And Restated 2024 Omnibus Incentive Plan; Amended Plan Increases Share Authorization By 2.85M Shares; Plan Termination Date Extended To May 28, 2036

Nu Skin Enterprises, Inc. (NYSE:NUS) Goes Ex-Dividend Soon

Nu Skin Enterprises' (NYSE:NUS) Profits May Not Reveal Underlying Issues

Nu Skin Enterprises Q1 Earnings Call Highlights

Nu Skin Enterprises, Inc. 2026 Q1 - Results - Earnings Call Presentation

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26

Nu Skin Enterprises, Inc. Q1 2026 Earnings Call Summary

Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript

Nu Skin Enterprises (NYSE:NUS) Reports Q1 2026 Earnings Miss Amid Ongoing Revenue Decline

Nu Skin Enterprises Lowers FY2026 GAAP EPS Guidance from $0.80-$1.20 to $0.70-$1.10 vs $1.00 Est; Affirms FY2026 Sales Guidance of $1.350B-$1.500B vs $1.427B Est